Tick borne encephalitis and Lyme borreliosis: Prevention before and after tick bite;Friuhsommermeningoenzephalitis und lyme-Borreliose: Pravention vor und nach zeckenstich

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 27, 1998, Pages 847-853

  Kaiser, R ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; IMMUNOGLOBULIN G;

HUMAN; IMMUNOTHERAPY; INFECTION PREVENTION; LYME DISEASE; REVIEW; TICK BITE; TICK BORNE ENCEPHALITIS; ANIMAL; BITES AND STINGS; GERMANY; MENINGOENCEPHALITIS; PROGNOSIS; RISK FACTOR; TICK;

ANIMALS; BITES AND STINGS; ENCEPHALITIS, TICK-BORNE; GERMANY; HUMANS; LYME DISEASE; MENINGOENCEPHALITIS; PROGNOSIS; RISK FACTORS; TICKS;

EID: 0032479085     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Ackermann, R., K. Krüger, M. Roggendorf, B. Rehse-Küpper, M. Mortter, M. Schneider, I. Vukadinovic: Verbreitung der Frühsommermeningoenzephalitis in Süddeutschland. Dtsch. med. Wschr. 111 (1986), 927-933.
2. Ackermann, R. und B. Rehse-Küpper: Die Zentraleuropäische Enzephalitis in der Bundesrepublik Deutschland. Fortschr. Neurol. Psychiat. 47 (1979), 103-122.
3. Anonymous: Pressemitteilung des Paul-Ehrlich-Instituts vom 30.08.96. Epidemiologisches Bulletin 36 (1996), 249.
4. Eistetter, S., P. Kimmig, R. Oehme: Untersuchungen zur Epidemiologie der FSME in Baden-Württemberg - Bestimmung der Zeckeninfektionsrate mit Hilfe eines modifizierten PCR-Verfahrens. Bundesgesundhbl. (1998), 62-65.
5. Fingerle, V., H. Bergmeister, G. Liegl, E. Vanek, B. Wilske: Prevalence of Borrelia burgdorferi sensu latu in Ixodes ricinus in Southern Germany. J. Spiroch. Tick Dis. 1 (1994), 41-45.
6. Gern, L., W. Burgdorfer, A. Aeschlimann, H. E. Krampitz: The ecology of Lyme borreliosis in Europe. In Weber, K., W. Burgdorfer (Ed): Aspects of Lyme borreliosis (Springer: Berlin, 1993), 59-69.
7. Gray, J.S., G. Stanek: Risk assessment in Lyme borreliosis; A »concerted action« in the EU biomedicine and health programme (1993-96). Zent. bl. Bakteriol. 287 (1998), 175-269.
8. Groll, E., C. Kunz, H. Moritsch: Untersuchungen über die Morbidität und stille Durchseuchung einer Population in einem Endemiegebiet der Frühsommer-Meningoencephalitis. Archiv ges. Virusforschung 15 (1965), 151-158.
9. Hauser, U., G. Lehnert, R. Lobentanzer, B. Wilske: Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J. Clin. Microbiol. 35 (1997), 1433-1444.
10. Heininger, U., T. Zimmermann, C. Schoerner, V. Brade, K. Stehr: Tick bite and Lyme borreliosis. An epidemiologic study in the Erlangen area. Monatsschr. Kinderheilkd. 141 (1993), 874-877.
11. Heinz, F.X., W. Tuma, C. Kunz: Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins. Infect. Immun. 33 (1981), 250-257.
12. Hubalek, Z., J. Halouzka: Prevalence rates of Borrelia burgdorferi sensu lato in host-seeking Ixodes ricinus ticks in Europe. Parasitol. Res. 84 (1998), 167-172.
13. Johnson, R.C.: Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo. Rev. Infect. Dis. 11 Suppl 6 (1989), S1505-1510.
14. Kahl, O., L. Gern, E. Gray, E. Guy, F. Jongejan, F. Kirstein, K. Kurtenbach, S. Rijpkema, G. Stanek: Detection of Borrelia burgdorferi sensu lato in ticks: immunofluorescence assay versus polymerase chain reaction. Zent. bl. Bakteriol. 287 (1998), 205-210.
15. Kahl, O., C. Janetzki-Mittmann, J. S. Gray, R. Jonas, J. Stein, R. de Boer: Risk of infection with Borrelia burgdorferi sensu lato for a host in relation to the duration of nymphal Ixodes ricinus feeding and the method of tick removal. Zent. bl. Bakteriol. 287 (1998), 41-52.
16. Kaiser, R.: Current TBE epidemiology in Baden-Württemberg, with special reference to illness despite passive immunisation. In J. Süss and O. Kahl (Ed): Tick-borne Encephalitis and Lyme Borreliosis (Pabst Science Publishers: Lengerich 1997), 135-143.
17. Kaiser, R.: FSME-Risikogebiete in Baden-Württemberg. Ärzteblatt Baden-Württemberg 4 (1998), 148.
18. Kersten, A., C. Poitschek, S. Rauch, E. Aberer: Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob. Agents Chemother. 39 (1995), 1127-1133.
19. Kluger, G., K. Waldvogel: Tick-borne encephalitis despite specific immunoglobulin prophylaxis. Lancet. 346 (1995), 1502.
20. Korenberg, E.I., N.N. Vorobyeva, H. G. Moskvitina, L.Ya. Gorban: Prevention of borreliosis in persons bitten by infected ticks. Infection 24 (1996), 187-189.
21. Kreil, T. R., M. M. Eibl: Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model. J. Virol. 71 (1997), 2921-2927.
22. Kunz, C., H. Hofmann, M. Kundi: Zur Wirksamkeit von FSME-Immunglobulin. Wien. klin. Wschr. 93 (1981), 665-667.
23. Magid, D., B. Schwartz, J. Craft, J. S. Schwartz: Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. New Engl. J. Med. 327 (1992), 534-541.
24. Maiwald, M., B. Oehme, O. March, T. N. Petney, P. Kimmig, K. Naser, H. A. Zappe, D. Hassler, M. von Knebel Doeberitz: Transmission risk of Borrelia burgdorferi sensu lato from Ixodes ricinus ticks to humans in southwestern Germany, Epidemiol. Infect. (1998) (im Druck).
25. Oschmann, P., W. Dorndorf: Therapie der Lyme Borreliose. Versicherungsmedizin 47 (1995), 79-83.
26. Paul, H., H. J. Gerth, R. Ackermann: Infectiousness fr humans of Ixodes ricinus containing Borrelia burgdorferi. Zent. bl. Bakteriol. 263 (1987), 473-476.
27. Peters, D. H., H. A. Friedel, D. McTavish: Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs. 44 (1992), 750-799.
28. Preac-Mursic, V., W. Marget, U. Busch, D. Pleterski Rigler, S. Hagl: Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis. Infection 24 (1996), 9-16.
29. Preac-Mursic, V.P., B. Wilske, G. Schierz, M. Holmburger, E. Süss: In vitro and in vivo susceptibility of Borrelia burgdorferi. Europ. J. Clin. Microbiol. 6 (1987), 424-426.
30. Rahn, D. W.: Antibiotic treatment of Lyme disease. Current recommendations by stage and extent of infection. Postgrad. Med. J. 91 (1992), 57-64.
31. Rieger, M. A., M. Nübling, M. Huwer, W. Müller, F. Hofmann: Untersuchungen zur Epidemiologie der Frühsommer-Meningoenzephalitis: Nehmen Rinder am Zyklus der Virusübertragung im südwestdeutschen Endemiegebiet teil? Erste Mitteilungen. Immun. Infekt. 2 (1997), 52-57.
32. Roggendorf, M.: Epidemiology of tick-borne encephalitis virus in Germany. Infection 24 (1996), 465-466.
33. Rose, C. D., P. T. Fawcett, S. C. Eppes, J. D. Klein, K. Gibney, R. A. Doughty: Pediatric Lyme arthritis: clinical spectrum and outcome. J. Pediatr. Orthop. 14 (1994), 238-241.
34. Roth, H., E. Mauch, U. Göbel: MIQ 1, Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. Nukleinsäureamplifikationstechniken. (Gustav Fischer: Stuttgart, 1997)
35. Schmidt, B. L.: PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin. Microbiol. Rev. 10 (1997), 185-201.
36. Schmutzhard, E., G. Stanek, M. Pletschette, A.M. Hirschl, A. Pallua, R. Schmitzberger, R. Schlögl: Infections following tickbites. Tickborne encephalitis and Lyme borreliosis - a prospective epidemiological study from Tyrol. Infection 16 (1998), 269-272.
37. Shapiro, E. D., M. A. Gerber, N. B. Holabird, A.T. Berg, H. M. Feder, Jr., G. L. Bell, P. N. Rys, D. H. Persing: A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. New Engl. J. Med. 327 (1992), 1769-1773.
38. Stanek, G., S. O'Connell, M. Cimmino, E. Aberer, W. Kristoferitsch, M. Granstrom, E. Guy, J. Gray: European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien. klin. Wschr. 108 (1996), 741-747.
39. Strle, F., V. Maraspin, S. Lotric-Furlan, E. Ruzic-Sabljic, J. Cimperman: Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. Infection 24 (1996), 64-68.
40. Süss, J., P. Beziat, C. Ramelow, O. Kahl: Tick-borne encephalitis virus (TBEV)-specific RT-PCR for characterization of natural foci of TBE and for other applications. Zent. bl. Bakterio. 286 (1997), 125-138.
41. Süss, J., C. Schrader, U. Abel: Zur Prävalenz des FSMEV in Zecken ausgewählter Standorte in den Naturherden Bayerns und Baden-Württembergs. (im Druck)
42. Valesova, H., J. Mailer, J. Havlik, D. Hulinska, J. Hercogova: Long-term results in patients with Lyme arthritis following treatment with ceftriaxone. Infection 24 (1996), 98-102.
43. von Hedenstrom, M., U. Heberle, K.Theobald: Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events. Vaccine 13 (1995), 759-762.
44. Waldvogel, K., W. Bossart, T. Huisman, E. Boltshauser, D. Nadal: Severe tick-borne encephalitis following passive immunization. Europ. J. Pediatr. 155 (1996), 775-779.
45. Wilske, B., V. Fingerle, U. Hauser, D. Rössler: Borrelien. Laboratoriums Medizin. Diagnostische Bibliothek (1997), 1-12.
46. Wormser, G. P.: Controversies in the use of antimicrobials for the prevention and treatment of Lyme disease. Infection 24 (1996), 178-181.